The Europe dental bone graft substitute and barrier membrane market is expected to grow from US$ 271.56 million in 2022 to US$ 517.88 million by 2030. It is estimated to grow at a CAGR of 8.4% from 2022 to 2030.
A periodontal disease can lead to the resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening and falling of the teeth. Therefore, the treatment of periodontal disease focuses on eliminating the source of infection, stimulating the synthesis of growth factors, and repairing periodontal tissue defects, ultimately restoring normal morphology and function. Correcting periodontal defects by bone grafting involves grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the Europe Dental Bone Graft Substitute and Barrier Membrane Market .
Based on product, the Europe dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the Europe dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the Europe dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on country, the Europe dental bone graft substitute and barrier membrane market is segmented into the Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, Matricel GmbH, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, CAMLOG Biotechnologies GmbH, and Resorba Medical GmbH are some of the leading companies operating in the Europe dental bone graft substitute and barrier membrane market.
Reasons to Buy
Increasing Burden of Periodontal Diseases and Oral Cancer Fuel Europe Dental Bone Graft Substitute and Barrier Membrane Market
Periodontal range from simple gingivitis to serious conditions that cause significant damage to the soft tissues and bones supporting teeth; in a serious case, patients may lose their teeth. According to the World Health Organisation (WHO), as of 2023, ~3.5 billion people are affected with oral diseases across the world. Further, periodontal diseases affect 19% of the adult population, representing more than 1 billion cases. Poor oral hygiene and tobacco chewing are the main risk factors for periodontal disease. As per an article published in the National Library of Medicine (NLM) in 2020, the risk of developing chronic systemic conditions such as autoimmune diseases and cancer increases with periodontitis. Several risk factors linked to periodontitis and oral cancer include smoking, alcohol consumption, and the human papillomavirus. According to the World Cancer Research Fund International, with ~377,700 cases recorded globally in 2020, lips and the oral cavity are the most common sites of mouth and oral cancer.A periodontal disease can lead to the resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening and falling of the teeth. Therefore, the treatment of periodontal disease focuses on eliminating the source of infection, stimulating the synthesis of growth factors, and repairing periodontal tissue defects, ultimately restoring normal morphology and function. Correcting periodontal defects by bone grafting involves grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the Europe Dental Bone Graft Substitute and Barrier Membrane Market .
Europe Dental Bone Graft Substitute and Barrier Membrane Market Overview
The European Europe Dental Bone Graft Substitute and Barrier Membrane Market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the Europe Dental Bone Graft Substitute and Barrier Membrane Market. Europe occupies a significant position in the Europe Dental Bone Graft Substitute and Barrier Membrane Market and is estimated to register a robust growth rate over the forecast period. The growth of the market in the region is attributed to the large number of procedures performed in the region, large geriatric population, and low costs of procedures in Eastern European countries. In addition, the rising medical tourism in Italy and Spain is likely to influence the market's growth during the forecast period.Europe Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)
Europe Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The Europe dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user, and country.Based on product, the Europe dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the Europe dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the Europe dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the Europe dental bone graft substitute and barrier membrane market in 2022.
Based on country, the Europe dental bone graft substitute and barrier membrane market is segmented into the Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, Matricel GmbH, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, CAMLOG Biotechnologies GmbH, and Resorba Medical GmbH are some of the leading companies operating in the Europe dental bone graft substitute and barrier membrane market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe dental bone graft substitute and barrier membrane market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe dental bone graft substitute and barrier membrane market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Europe Dental Bone Graft Substitute and Barrier Membrane Market Landscape
5. Europe Dental Bone Graft Substitute and Barrier Membrane Market - Key Industry Dynamics
6. Dental Bone Graft Substitute and Barrier Membrane Market - Europe Market Analysis
7. Europe Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Product
8. Europe Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Procedures
9. Europe Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by End User
10. Europe Dental Bone Graft Substitute and Barrier Membrane Market - Country Analysis
11. Europe Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape
12. Europe Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Geistlich Pharma AG
- Medtronic Plc
- Dentsply Sirona Inc
- Matricel GmbH
- ZimVie Inc
- Regenity Biosciences Inc
- Neoss UK & Ireland Ltd
- Institut Straumann AG
- CAMLOG Biotechnologies GmbH
- Resorba Medical GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 115 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 271.56 Million |
| Forecasted Market Value by 2030 | 517.88 Million |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Europe |
